Cancer Patients With Breakthrough COVID-19 Remain at Risk for Severe Outcomes
Patients with cancer who develop breakthrough infection following COVID-19 vaccination remain at risk for severe outcomes.
Oncology
Severe Visual Field Defects Associated With Blood Vessel Absence
Impaired blood vessel network formation is associated with more severe visual field defects, according to the study.
Antiemetic Treatments
Antiemetic treatment chart including drug formulations, strengths, and usual doses for nausea/vomiting.
Chemotherapy-Induced Nausea and Vomiting Guidelines: Prophylaxis
The ASCO guideline provides updated recommendations for the prevention and management of chemotherapy-induced nausea and vomiting (CINV) based on the emetic risk of the treatment regimen.
Emetogenic Potential of Antineoplastic Agents
Emetogenic potential (high, moderate, low, or minimal risk) of oral and injectable antineoplastic agents.
FDA-Approved Biosimilars
A comparative list of biosimilars approved by the FDA including their reference products, dosage forms and indications.
FDA-Approved Breast Cancer Treatments
FDA-approved oral and injectable treatment options for breast cancer.
FDA-Approved Colorectal Cancer Treatments
Colorectal cancer treatment regimen chart.
FDA-Approved Non-Small Cell Lung Cancer (NSCLC) Treatments
Chemotherapeutic and biologic agents for the treatment of non-small cell lung cancer (NSCLC).
FDA-Approved Ovarian Cancer Treatments
FDA-Approved treatment options for individuals with ovarian cancer including dosing.
- Loading...
Loading...
Loading... 
Loading...